Hot flashes are the widely seen symptom of menopause and perimenopause in women across the world. The symptom is also seen among women who initiate menopause after chemotherapies or under ovaries removal surgery. The treatment for hot flashes is widely done by using non-hormonal or hormonal products.
Stable cell lines are widely used in a wide range application, including biologics production, drug screening, and gene functional studies. The COVID-19 pandemic led to disruptions in all phases of drug development, and it has compelled many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold. The new government policies, stay-at-home orders, social distancing norms, and widespread anxiety are among the prime challenges faced by researchers conducting the ongoing studies.